Cyanotech Corporation (Nasdaq Capital Market: CYAN), the world innovation leader in the cultivation and manufacture of microalgae for health and nutrition, including BioAstin® Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica®, today announces the appointment of Collette Kakuk as Chief Strategic and Commercial Officer. Ms. Kakuk brings an impressive background in business development, strategy, and marketing to add significant value to Cyanotech’s growing stable of products. Her industry experience, combined with a passionate drive for sustainable and authentic product sourcing, makes her an ideal addition to Cyanotech’s executive team.

Recognizing growing global interest in microalgae and its health benefits, Ms. Kakuk is excited about the company’s future. “Today’s consumers are not only looking for more natural, healthy products – they also want them responsibly produced. I am deeply impressed by Cyanotech’s longstanding commitment to natural, sustainable production,” said Kakuk. “Growing microalgae in open ponds, under natural sunlight, with fresh lava filtered water is as old as time – offering the world of health and wellness access to the abundant benefits of this geologically unique location. I aim to tell the story of Hawaiian quality and authenticity, while defining and upholding industry standards to ensure public confidence in our category of wellness.”

Cyanotech’s President and Chief Executive Officer, Matthew K. Custer, affirms that Ms. Kakuk’s appointment to the senior leadership team marks a moment of opportunity for the company. “Collette brings a dual perspective,” Custer said. “She is both an accomplished, creative, and inspired business leader - but also remains deeply connected to the mindset of a discriminating consumer, who researches and curates only the best healthy products for her family. She readily understands the distinguishing features of our products on a profound level.”

“Being a vertically integrated, health and wellness ingredient and finished goods company located in Hawaii, there is no corporate calling more authentic, nor compelling, than our unwavering commitment to care for people and the environment,” said Kakuk. “As a company, this is not an add on or fleeting trend for us. It’s the essence of who Cyanotech is, and has been, since day one.”

About Cyanotech: Cyanotech Corporation is the world leader in microalgae technology, production and innovation, including sustainably grown and harvested, top quality BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. For more than 30 years, Cyanotech has served the world’s leading food, beverage, dietary supplement, personal care, retail, and pet brands. Cyanotech produces and innovates bulk microalgae ingredients for health and wellness, in addition to also producing finished goods. Cyanotech’s BioAstin® Hawaiian Astaxanthin® offers superior antioxidant activity to support skin, eye and joint health, as well as recovery from exercise*. Cyanotech's Spirulina products offer nutrition to provide cardiovascular health and immune support*. All Cyanotech products are naturally and sustainably produced from microalgae grown on a purpose-built 96-acre facility in Kona, Hawaii using patented and proprietary technology, and are Generally Recognized as Safe (“GRAS”) for use in food products. In addition to selling bulk ingredients, Cyanotech also sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.com. The Company is regulated by the Food and Drug Administration. Visit www.cyanotech.com for more information.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Cyanotech Public Relations Contact: Bruce Russell (310) 346-6131 brussell@cyanotech.com

Grafico Azioni Cyanotech (NASDAQ:CYAN)
Storico
Da Mar 2025 a Mar 2025 Clicca qui per i Grafici di Cyanotech
Grafico Azioni Cyanotech (NASDAQ:CYAN)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di Cyanotech